AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like Aurora Diagnostics Inc. Acquires April 11, 2016 Tiny Massachusetts Biotech Corbus to Triple HQ Space to Accommodate Growth September 19, 2017 Bay Area Versartis's Stock Collapses as Growth Hormone Drug Flunks Phase III Test September 21, 2017
